We present the first comprehensive report on the distribution and genotype-phenotype correlations of CF-causing mutations in Western Ukraine (former Galicia). The 2184insA mutation was identified in 17 unrelated CF patients, 2 of whom are homozygotes for this allele. This mutation is associated with the classical form of CF. The high frequency of 2184insA mutation (7.20% of all mutated CF chromosomes) suggests that it is likely of Galician origin, from where it has spread throughout Europe and beyond. The achieved 83.71% mutation detection rate fulfills the minimal pre-requisite for introduction of the "two-tier" (IRT/DNA) newborn screening program.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcf.2010.06.001 | DOI Listing |
Respir Investig
May 2024
Department of Medicine, University of Verona, Division of General Pathology, Cystic Fibrosis Laboratory D. Lissandrini, Strada le Grazie 8, 37134, Verona, Italy. Electronic address:
Background: Many disease-causing variants in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene remain uncharacterized and untreated. Restoring the function of the impaired CFTR protein is the goal of personalized medicine, particularly in patients carrying rare CFTR variants. In this study, functional defects related to the rare R334W variant were evaluated after treatment with CFTR modulators or Roflumilast, a phosphodiesterase-4 inhibitor (PDE4i).
View Article and Find Full Text PDFJ Asthma
June 2024
Centre for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan.
Objective: Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the gene. This study aimed to identify the spectrum of variants reported in individuals with CF from South Asia (ISA).
Data Sources And Study Selection: We conducted a PubMed search for variants reported in ISA.
Int J Mol Sci
November 2023
Research Centre for Medical Genetics, 115522 Moscow, Russia.
Pathogenic variants cause cystic fibrosis (CF), and CF-related disorders (CF-RD), including bilateral aplasia of the vas deferens (CBAVD). The spectrum of clinical manifestations depends on the genotype. The frequency and spectrum of the variants vary between populations and clinical groups.
View Article and Find Full Text PDFGenes (Basel)
July 2023
Research Centre for Medical Genetics, 115522 Moscow, Russia.
(1) Introduction: Pathogenic variants in the (Cystic Fibrosis Transmembrane conductance Regulator, OMIM: 602421) gene cause Cystic Fibrosis (CF, OMIM: 219700) and CF-related disorders (CF-RD), often accompanied by obstructive azoospermia due to congenital bilateral aplasia of vas deferens (CBAVD, OMIM: 277180) in male patients. The L138ins (c.413_415dup; p.
View Article and Find Full Text PDFOrv Hetil
December 2022
1 Debreceni Egyetem, Általános Orvostudományi Kar, Laboratóriumi Medicina Intézet, Klinikai Genetikai Tanszék Debrecen, Nagyerdei krt. 98., 4032 Magyarország.
Introduction: Cystic fibrosis (CF) is one of the most common monogenic diseases. Genetic testing is becoming increasingly reasoned to establish or confirm the diagnosis by detecting abnormal mutations.
Objective: In order to develop a diagnostic strategy for cystic fibrosis and to facilitate mutation-specific treatments, the genetic revision of the Hungarian Cystic Fibrosis Registry was performed.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!